You just read:

FDA Approves Bio Products Laboratory's Gammaplex® 10% for Treatment of Primary Immunodeficiency and Chronic Immune Thrombocytopenic Purpura

News provided by

Bio Products Laboratory Limited

Feb 07, 2017, 09:30 ET